Institutionelle bei Millennium Pharma

Im Folgenden steht an erster Stelle der Name des institutionellen Shareholders bzw. Fonds, an zweiter Stelle die Anzahl der gehaltenen Aktien und an dritter Stelle der Wert des gehaltenen Aktienpakets.

Institutionelle Shareholder
Citigroup Inc. 7,817,332 $107,566,488
Taunus Corporation 6,071,629 $83,545,615
Barclays Bank Plc 5,954,288 $81,931,002
FMR Corporation (Fidelity Management & Research Corp) 39,998,150 $550,374,544
Janus Capital Management, LLC 5,550,315 $76,372,334
Morgan Stanley 4,277,685 $58,860,945
State Street Corporation 3,633,374 $49,995,226
Dresdner Bank Ag 3,383,420 $46,555,859
JP Morgan Chase & Company 3,375,589 $46,448,104
AXA Financial, Inc. 2,851,485 $39,236,433

Topliste der investierten Fonds
Fidelity Growth Company Fund 13,149,477 $180,936,803
Fidelity Select Portfolios - Biotechnology 7,881,762 $108,453,045
Fidelity Aggressive Growth Fund 6,966,778 $95,862,865
Homestead Funds Inc-Nasdaq 100 Index Tracking Stock Fund 4,697,460 $64,637,049
Janus Mercury Fund 3,151,895 $43,370,075
Smith Barney Aggressive Growth Fund Inc. 2,961,900 $40,755,744
Variable Insurance Products Fd-Growth Portfolio 2,555,380 $35,162,028
UBS (Lux) Biotech 2,081,028 $28,634,945
Finex Fonds Bio Spezial 1,777,140 $24,453,446
Fidelity Advisor Equity Growth Fund 1,753,400 $24,126,784